JOHNSON & JOHNSON revenue breakdown overview

JOHNSON & JOHNSON revenue for the last year amounted to 85.80 B EUR, the most of which — 55.03 B EUR — came from its highest performing source at the moment, Innovative Medicine, the year earlier bringing 49.61 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought JOHNSON & JOHNSON 48.59 B EUR, and the year before that — 42.08 B EUR.